Calendar Oncolytics Biotech Inc. Nasdaq

Equities

ONCY

CA6823108759

Market Closed - Nasdaq 21:00:00 31/05/2024 BST 5-day change 1st Jan Change
1.07 USD -0.93% Intraday chart for Oncolytics Biotech Inc. -1.83% -20.74%

Chart calendar Oncolytics Biotech Inc.

f01d44c032e1a1d94e72cece0.2LXBgs1y6bv5jRavjxMkh72GgCgyLgBb2TRhcSQbF14.oP353aEQvcmW1WHlwH5q5o314UN9Wmo1mHE-SW1fOiue-K7H_ULd0cHkcQ~41acd5b23f45440bb95f105714ff721a

Upcoming events on Oncolytics Biotech Inc.

12/08/2024 Q2 2024 Earnings Release (Projected)
12/11/2024 Q3 2024 Earnings Release (Projected)
05/03/2025 Q4 2024 Earnings Release (Projected)
01/05/2025 Q1 2025 Earnings Release (Projected)

Past events on Oncolytics Biotech Inc.

01/06/2024 19:30 American Society of Clinical Oncology Meeting - Abstract Number: TPS4203
30/05/2024 American Society of Clinical Oncology Meeting - Abstract Number: e14625
23/05/2024 22:00 American Society of Clinical Oncology Meeting - Abstract Number: e14625
15/05/2024 21:00 Annual General Meeting
15/05/2024 15:30 RBC Capital Markets Global Healthcare Conference
09/05/2024 21:30 Q1 2024 Earnings Call
09/05/2024 21:01 Q1 2024 Earnings Release
15/04/2024 14:00 CG Horizons in Oncology Virtual Conference - Viral Approaches in Oncology
07/03/2024 21:30 Q4 2023 Earnings Call
07/03/2024 21:01 Q4 2023 Earnings Release
01/03/2024 16:30 Cancer Advocacy Group of Louisiana NeauxCancer Conference
08/11/2023 International Multidisciplinary Anal Cancer Conference
04/11/2023 16:00 Society for Immunotherapy of Cancer Meeting - Abstract Number - 582
03/11/2023 12:30 Q3 2023 Earnings Call
03/11/2023 11:00 Q3 2023 Earnings Release
22/10/2023 European Society for Medical Oncology Congress - Abstract Number:1623P
21/10/2023 European Society for Medical Oncology Congress - Abstract Number:619P
27/09/2023 13:35 Cantor Global Healthcare Conference - Fireside Chat
12/09/2023 14:30 H.C. Wainwright Global Investment Conference
14/08/2023 13:30 Q2 2023 Earnings Call

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million CAD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

1,00

EBITDA
Million CAD
Released
Forecast
Spread
-20,6
-25,5
19.33%
-25,0
-21,8
-14.72%
-26,1
-26,3
0.56%
-26,5
-24,3
-9.19%
-33,4
-35,3
5.42%

-41,8

EBIT
Million CAD
Released
Forecast
Spread
-20,7
-17,4
-18.59%
-26,1
-23,6
-10.67%
-26,2
-28,3
7.23%
-26,9
-24,7
-8.81%
-33,8
-35,3
4.37%

-39,3

Earnings before Tax (EBT)
Million CAD
Released
Forecast
Spread
-33,1
-17,4
-90.62%
-22,5
-20,2
-11.42%
-26,3
-26,6
1.26%
-24,8
-22,5
-9.98%
-27,7
-33,9
18.38%

-34,1

Net income
Million CAD
Released
Forecast
Spread
-33,1
-19,5
-70.12%
-22,5
-20,1
-12.19%
-26,3
-25,7
-2.37%
-24,8
-23,7
-4.97%
-27,8
-33,9
18.22%

-34,0

EPS
CAD
Released
Forecast
Spread
-1,50
-0,87
-72.91%
-0,56
-0,49
-14.75%
-0,49
-0,46
-5.95%
-0,43
-0,40
-7.45%
-0,41
-0,50
18.39%

-0,40

Announcement Date05/03/2005/03/2103/03/2203/03/2307/03/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million CAD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00


0,00


1,20


0,00

EBITDA
Million CAD
Released
Forecast
Spread
-7,43
-9,49
21.68%
-6,21
-8,30
25.17%
-5,95
-6,62
10.12%
-5,96
-7,00
14.83%
-8,41
-6,10
-37.85%
-6,64
-8,44
21.35%
-7,06
-7,18
1.68%
-10,9
-7,35
-48.88%
-8,74
-10,7
18.3%
-8,60
-8,90
3.34%

-9,90


-11,0


-14,1




EBIT
Million CAD
Released
Forecast
Spread
-7,45
-9,54
21.85%
-6,31
-8,30
23.99%
-6,05
-6,62
8.64%
-6,06
-6,57
7.72%
-8,51
-6,35
-34.09%
-6,73
-8,16
17.44%
-7,16
-7,17
0.13%
-11,0
-7,44
-48.41%
-8,85
-10,4
15.08%
-8,73
-8,53
-2.27%

-9,17


-9,77


-11,6




Earnings before Tax (EBT)
Million CAD
Released
Forecast
Spread
-7,71
-8,40
8.25%
-6,78
-8,19
17.23%
-5,07
-6,88
26.32%
-4,40
-6,48
32.05%
-8,50
-6,27
-35.49%
-6,44
-8,14
20.89%
-7,39
-6,99
-5.74%
-9,92
-7,32
-35.41%
-3,91
-10,2
61.54%
-6,89
-8,35
17.46%

-8,82


-9,32


-9,35




Net income
Million CAD
Released
Forecast
Spread
-7,75
-8,40
7.75%
-6,78
-8,19
17.23%
-5,09
-6,88
25.96%
-4,41
-6,48
32.01%
-8,55
-6,27
-36.4%
-6,44
-8,14
20.89%
-7,44
-6,99
-6.41%
-9,93
-7,32
-35.51%
-3,95
-10,2
61.12%
-6,89
-8,35
17.46%

-8,82


-9,32


-9,35




EPS
CAD
Released
Forecast
Spread
-0,14
-0,13
-10.52%
-0,12
-0,14
16.28%
-0,09
-0,11
15.63%
-0,08
-0,11
27.27%
-0,15
-0,10
-54.64%
-0,10
-0,13
23.43%
-0,12
-0,11
-5.82%
-0,14
-0,11
-29.39%
-0,05
-0,15
65.61%
-0,09
-0,11
18.31%

-0,10


-0,11


-0,09


-0,11

Announcement Date03/03/2205/05/2211/08/2207/11/2203/03/2305/05/2314/08/2303/11/2307/03/2409/05/24----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. ONC Stock
  4. ONCY Stock
  5. Calendar Oncolytics Biotech Inc.